ArticleBMC pulmonary medicine2021

Response to pembrolizumab in a patient with primary lung adenocarcinoma originated from indium lung.

Yasuharu Sekine et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.